相关实验视频
Updated: Jul 9, 2025

05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.2K
骨关节炎中的衰老:机制和治疗方法的概述
Natalya Surmachevska1, Jose Rubio1
1Beth Israel Deaconess Medical Center, Boston, USA; Harvard Medical School, Boston, USA.
European journal of rheumatology
|November 28, 2023
概括
细胞衰老通过释放炎症蛋白质,有助于骨关节炎. 针对老化细胞的疗法,如老化药和老化药,正在探索有效的骨关节炎治疗.
科学领域:
- 风湿病学和细胞生物学
- 研究细胞衰老在骨关节炎发病过程中的作用.
背景情况:
- 骨关节炎 (OA) 是一种普遍的,使人虚弱的疾病,有效治疗方法有限.
- 骨关节炎的确切病理生理学仍然不清楚,但细胞衰老越来越被认为是导致的因素.
- 关节组织的衰老,包括软骨细胞,突细胞和脂肪细胞,通过释放与衰老相关的蛋白质驱动OA.
研究的目的:
- 探索细胞衰老对骨关节炎的贡献.
- 审查用于骨关节炎治疗的衰老修饰疗法.
主要方法:
- 关于骨关节炎病理生理学和细胞衰老的当前文献的综述.
- 分析老化相关蛋白质 (细胞因子,矩阵降解酶,化学因子) 在OA中的作用.
- 对老化和老形治疗策略的检查.
主要成果:
- 关节组织中的细胞衰老通过衰老相关的蛋白质生产促进炎症环境.
- 这种炎症环境延续了衰老的循环,加剧了OA.
- 老化剂 (消除衰老细胞) 和老化剂 (抑制衰老相关的蛋白质产生) 是关键的治疗方法.
结论:
- 细胞衰老是骨关节炎发病的一个重要因素.
- 准细胞衰老为新型骨关节炎治疗提供了一个有希望的途径.
- 试验性疗法包括新的药物和从风湿病学和其他领域重新使用的药物.
相关概念视频
Aging
56
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
56
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Mitochondria
13.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
13.3K
Alzheimer's Disease: Overview
494
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195

